Skip to main content
European Commission logo print header

Multidimensional ultrasonic scanning technology to reduce cancer death rate through fast and accurate diagnosis particularly of breast cancer

Objective

In Europe this year 100,000 women will die of Breast Cancer. It is the largest single cause of death in womeni across the entire 35 65 ages group The exact progress of the growth of a tumour is difficult to map; tumours don't really follow growth guidelines. What we do know is that once a tumour in the breast has grown to 2cm diameter there is already a 40-50% chance that secondary cancers exist. To set this in context, breast cancer accounts for 31 deaths in 100,000 women every year. This also equates to 31 deaths out of 75 sufferers or a little over 40% of diagnosed breast cancer resulting in mortality. Dividing those figures into pre and post secondary cancer the figures are stark. Breast cancers that are detected prior to any secondary presence result in 20% mortality whereas in cases where secondary cancers are present the result is 65% mortality. Of the 100,000 women who will die of breast cancer this year about 70,000 will die from cancer that was not detected until secondary tumours (metastases) were present. Had they been diagnosed earlier, pre-metastases, nearly 50,000 of them would have lived. Diagnosis is key.

Call for proposal

Data not available

Coordinator

MEDCOM GMBH
EU contribution
No data
Address
Rundeturmstrasse 12
DARMSTADT
Germany

See on map

Total cost
No data

Participants (6)